在癌症中表观遗传学,衰老和细胞氧化还原代谢之间的相互作用及其治疗影响
Geoffrey Balamurli1, Angeline Qiu Xia Liew2, Wee Wei Tee1
1Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore; NUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, NUS, Singapore; Chromatin Dynamics and Disease Epigenetics Lab, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore.
Redox biology
|November 29, 2024
概括
癌症的进展涉及表观遗传变化,细胞循环停止 (衰老) 和细胞氧化还原代谢之间的复杂相互作用. 了解这种相互作用为针对这些相互关联的过程提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 细胞生长和增殖受到影响癌症的分子事件的严格调节.
- 表观遗传修饰,衰老和氧化还原代谢是致癌的关键因素.
研究的目的:
- 审查在癌症中的表观遗传变化,衰老和细胞氧化还原代谢之间的相互作用.
- 突出这些过程如何影响瘤进展和治疗策略.
主要方法:
- 文献综述侧重于表观遗传学,衰老和氧化还原代谢之间的交叉交流.
- 对表观遗传变化如何影响瘤转录组和表型的分析.
- 检查衰老作为瘤发生的双刃剑.
主要成果:
- 表观遗传变化动态影响瘤转录组,表型,生存,生长和扩散.
- 由表观遗传变化引发的衰老可以抑制瘤或促进癌症的进展.
- 异常的氧化还原代谢将表观遗传与衰老联系在一起,影响信号传递和基因组稳定性.
结论:
- 表观遗传学,衰老和氧化还原代谢之间的相互联系为癌症提供了微妙的看法.
- 治疗干预可以同时针对表观遗传修饰,衰老动态和氧化还原平衡.
相关概念视频
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Electron Transport Chain: Complex I and II
11.7K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.7K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Telomeres and Telomerase
5.1K
5.1K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K


